{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:41:48Z","timestamp":1790401308683,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.clim.2016.09.010","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T23:51:47Z","timestamp":1474501907000},"page":"29-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["An emerging role for eotaxins in neurodegenerative disease"],"prefix":"10.1016","volume":"189","author":[{"given":"Amanda K.","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.09.010_bb0005","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1006\/bbrc.1994.2734","article-title":"Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs","volume":"205","author":"Jose","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2016.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1172\/JCI6560","article-title":"Fundamental signals that regulate eosinophil homing to the gastrointestinal tract","volume":"103","author":"Mishra","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.09.010_bb0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm0496-449","article-title":"Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia","volume":"2","author":"Garcia-Zepeda","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2016.09.010_bb0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI5669","article-title":"Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis","volume":"103","author":"Spergel","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.09.010_bb0025","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1084\/jem.183.6.2437","article-title":"Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils","volume":"183","author":"Ponath","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.09.010_bb0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1172\/JCI118456","article-title":"Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils","volume":"97","author":"Ponath","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.09.010_bb0035","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1084\/jem.185.12.2171","article-title":"Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes","volume":"185","author":"Forssmann","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.09.010_bb0040","doi-asserted-by":"crossref","first-page":"27975","DOI":"10.1074\/jbc.274.39.27975","article-title":"Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3","volume":"274","author":"Kitaura","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2016.09.010_bb0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.clim.2016.09.010_bb0050","doi-asserted-by":"crossref","first-page":"42957","DOI":"10.1074\/jbc.M103933200","article-title":"The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b","volume":"276","author":"Martinelli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2016.09.010_bb0055","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1182\/blood.V97.7.1920","article-title":"Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5","volume":"97","author":"Ogilvie","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.09.010_bb0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood-2002-09-2773","article-title":"Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes","volume":"102","author":"Ogilvie","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.09.010_bb0065","doi-asserted-by":"crossref","first-page":"23357","DOI":"10.1074\/jbc.M309283200","article-title":"Eotaxin-3\/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role","volume":"279","author":"Petkovic","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2016.09.010_bb0070","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.4049\/jimmunol.0904126","article-title":"Eotaxin-3\/CC chemokine ligand 26 is a functional ligand for CX3CR1","volume":"185","author":"Nakayama","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0075","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.169.5.2712","article-title":"Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers","volume":"169","author":"Menzies-Gow","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0080","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1084\/jem.194.12.1699","article-title":"Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3","volume":"194","author":"Cuvelier","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.09.010_bb0085","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.clim.2016.09.010_bb0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000053694","article-title":"Expression of the chemokine receptor CCR3 on human mast cells","volume":"124","author":"de Paulis","year":"2001","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0095","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.neuroscience.2014.10.062","article-title":"Evidence for the contribution of adult neurogenesis and hippocampal cell death in experimental cerebral malaria cognitive outcome","volume":"284","author":"de Miranda","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.clim.2016.09.010_bb0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/cei.12117","article-title":"Regulation of eotaxin-3\/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts","volume":"173","author":"Takahashi","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0105","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MPA.0000000000000480","article-title":"Eotaxin-3 (CCL26) expression in human pancreatic myofibroblasts","volume":"45","author":"Fujimoto","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.clim.2016.09.010_bb0110","doi-asserted-by":"crossref","first-page":"L478","DOI":"10.1152\/ajplung.00032.2005","article-title":"Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation","volume":"289","author":"Abonyo","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.clim.2016.09.010_bb0115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1165\/rcmb.2007-0337OC","article-title":"Differential regulation of eotaxin expression by dexamethasone in normal human lung fibroblasts","volume":"38","author":"Suzuki","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.clim.2016.09.010_bb0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000089923","article-title":"Human airway smooth muscle cells express eotaxin in response to signaling following mast cell contact","volume":"73","author":"Liu","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.clim.2016.09.010_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1465-9921-6-74","article-title":"Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle","volume":"6","author":"Oltmanns","year":"2005","journal-title":"Respir. Res."},{"issue":"Suppl 1","key":"10.1016\/j.clim.2016.09.010_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000059413","article-title":"Histamine and serotonin stimulate eotaxin production by a human lung fibroblast cell line","volume":"128","author":"Sato","year":"2002","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1189\/jlb.1212640","article-title":"CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis","volume":"94","author":"Lampinen","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2016.09.010_bb0140","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.4049\/jimmunol.1200057","article-title":"Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA\/p65 in mice","volume":"190","author":"Waddell","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/jc.2005-1280","article-title":"Eotaxin and obesity","volume":"91","author":"Vasudevan","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clim.2016.09.010_bb0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bone.2012.12.006","article-title":"Chemokine expression is upregulated in chondrocytes in diabetic fracture healing","volume":"53","author":"Alblowi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.clim.2016.09.010_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0091-6749(00)90187-8","article-title":"Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines","volume":"105","author":"Fujisawa","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0160","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1081-1206(10)61399-3","article-title":"Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB","volume":"93","author":"Kobayashi","year":"2004","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0165","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.4049\/jimmunol.171.8.4369","article-title":"Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR","volume":"171","author":"Atasoy","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0170","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2222.2004.1954.x","article-title":"Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts","volume":"34","author":"Nonaka","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.clim.2016.09.010_bb0175","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.4049\/jimmunol.1300460","article-title":"Alendronate attenuates eosinophilic airway inflammation associated with suppression of Th2 cytokines, Th17 cytokines, and eotaxin-2","volume":"191","author":"Sasaki","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bjp.0703866","article-title":"beta(2)-Adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells","volume":"132","author":"Hallsworth","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clim.2016.09.010_bb0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4049\/jimmunol.175.1.478","article-title":"beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation","volume":"175","author":"Nie","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0190","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1084\/jem.20061401","article-title":"Interleukin-17 is a negative regulator of established allergic asthma","volume":"203","author":"Schnyder-Candrian","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.09.010_bb0195","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.fct.2013.05.020","article-title":"Fumaric acid attenuates the eotaxin-1 expression in TNF-alpha-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-kappaB signaling","volume":"58","author":"Roh","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.clim.2016.09.010_bb0200","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.114.213074","article-title":"Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells","volume":"349","author":"Erickson","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clim.2016.09.010_bb0205","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1073\/pnas.1211270110","article-title":"CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging","volume":"110","author":"Baruch","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.09.010_bb0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1742-2094-8-139","article-title":"Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide","volume":"8","author":"Kovac","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2016.09.010_bb0215","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/glia.22892","article-title":"CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia","volume":"63","author":"Parajuli","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.clim.2016.09.010_bb0220","first-page":"1083","article-title":"Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation","volume":"13","author":"Yang","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.clim.2016.09.010_bb0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1634\/stemcells.22-1-109","article-title":"Chemokines promote quiescence and survival of human neural progenitor cells","volume":"22","author":"Krathwohl","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.clim.2016.09.010_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function","volume":"477","author":"Villeda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clim.2016.09.010_bb0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2016.09.010_bb0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clim.2016.09.010_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030525","article-title":"CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease","volume":"7","author":"Westin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.09.010_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0197-4580(00)00094-4","article-title":"Microglia, amyloid and dementia in Alzheimer disease. A correlative study","volume":"21","author":"Arends","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.clim.2016.09.010_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064971","article-title":"Inflammatory proteins in plasma are associated with severity of Alzheimer's disease","volume":"8","author":"Leung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.09.010_bb0260","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3988\/jcn.2008.4.2.84","article-title":"Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology","volume":"4","author":"Choi","year":"2008","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0265","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","article-title":"Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease","volume":"69","author":"Soares","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0270","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","article-title":"A serum protein-based algorithm for the detection of Alzheimer disease","volume":"67","author":"O'Bryant","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0275","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-010-0667-0","article-title":"Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment","volume":"119","author":"Hu","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clim.2016.09.010_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis","volume":"6","author":"Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.09.010_bb0285","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0290","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.09.010_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1231","article-title":"Abnormal peripheral chemokine profile in Huntington's disease","volume":"3","author":"Wild","year":"2011","journal-title":"PLoS Curr."},{"key":"10.1016\/j.clim.2016.09.010_bb0300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/21646821.2015.1075181","article-title":"Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases: an overview","volume":"55","author":"Morris","year":"2015","journal-title":"Neurodiagn. J."},{"key":"10.1016\/j.clim.2016.09.010_bb0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","article-title":"A comprehensive review of amyotrophic lateral sclerosis","volume":"6","author":"Zarei","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"10.1016\/j.clim.2016.09.010_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2014.07.059","article-title":"Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy","volume":"346","author":"Furukawa","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clim.2016.09.010_bb0315","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000232025.84238.e1","article-title":"Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis","volume":"65","author":"Tanaka","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0320","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2010.03.004","article-title":"CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis","volume":"222","author":"Tateishi","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0325","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis","volume":"72","author":"Mitchell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2016.09.010_bb0330","article-title":"CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy","volume":"2","author":"Furukawa","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"key":"10.1016\/j.clim.2016.09.010_bb0335","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","article-title":"Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis","volume":"16","author":"Kuhle","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0340","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1521-6616(02)00028-1","article-title":"Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis","volume":"106","author":"Filion","year":"2003","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0345","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.94.2.599","article-title":"Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand","volume":"94","author":"Balashov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.09.010_bb0350","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.177.6.4196","article-title":"Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response","volume":"177","author":"Karni","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0165-5728(02)00018-8","article-title":"IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions","volume":"125","author":"Karni","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0360","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0000000000000908","article-title":"Dysregulation of the IL-23\/IL-17 axis and myeloid factors in secondary progressive MS","volume":"83","author":"Huber","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2016.09.010_bb0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2006.05.049","article-title":"Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis","volume":"247","author":"Franciotta","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clim.2016.09.010_bb0370","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2013.07.019","article-title":"Post-acute serum eosinophil and neutrophil-associated cytokine\/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study","volume":"64","author":"Michael","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2016.09.010_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128952","article-title":"Plasma biomarkers discriminate clinical forms of multiple sclerosis","volume":"10","author":"Tejera-Alhambra","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.clim.2016.09.010_bb0380","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"Weiner","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0385","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder?","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.clim.2016.09.010_bb0390","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0395","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0400","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-015-0329-1","article-title":"Functional differences between microglia and monocytes after ischemic stroke","volume":"12","author":"Ritzel","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.clim.2016.09.010_bb0405","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00701-006-1095-8","article-title":"Kinetics of the cellular immune response following closed head injury","volume":"149","author":"Czigner","year":"2007","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.clim.2016.09.010_bb0410","first-page":"4284","article-title":"Bridge between neuroimmunity and traumatic brain injury","volume":"20","author":"Kelso","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.clim.2016.09.010_bb0415","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/cne.10554","article-title":"Developmental changes in the expression of chemokine receptor CCR1 in the rat cerebellum","volume":"457","author":"Cowell","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.clim.2016.09.010_bb0420","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/glia.10181","article-title":"Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation","volume":"41","author":"Croitoru-Lamoury","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.clim.2016.09.010_bb0425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/exmp.2000.2336","article-title":"Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia","volume":"69","author":"van der Meer","year":"2000","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.clim.2016.09.010_bb0430","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0165-5728(03)00009-2","article-title":"Regulation of chemokine receptor expression in human microglia and astrocytes","volume":"136","author":"Flynn","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2016.09.010_bb0435","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1128\/JVI.72.4.3351-3361.1998","article-title":"Role of the beta-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia","volume":"72","author":"Ghorpade","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2016.09.010_bb0440","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9440(10)65542-3","article-title":"Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains","volume":"153","author":"Xia","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2016.09.010_bb0445","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0960-9822(06)00055-8","article-title":"CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons","volume":"7","author":"Hesselgesser","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.clim.2016.09.010_bb0450","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jnr.10304","article-title":"Fractalkine and fractalkine receptors in human neurons and glial cells","volume":"69","author":"Hatori","year":"2002","journal-title":"J. Neurosci. Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616304004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616304004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T05:30:32Z","timestamp":1601098232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616304004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":90,"alternative-id":["S1521661616304004"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.09.010","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An emerging role for eotaxins in neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}